VIKING GLOBAL INVESTORS LP

Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 13,026,367 shares
Security Ownership %: 6.8%

Shares, Excluding Options vs Price

Value, Excluding Options

VIKING GLOBAL INVESTORS LP ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

17 Feb 2026 - VIKING GLOBAL INVESTORS LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,026,367 shares of BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO). This represents 6.8% ownership of the company. In their previous filing dated 14 Nov 2025, VIKING GLOBAL INVESTORS LP had reported owning 15,893,934 shares, indicating a decrease of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
VIKING GLOBAL INVESTORS LP	6.8%	-18%	$1,040,936,987	13,026,367	-2,867,567	-18%	$79.91	13D/A	12 Feb 2026	17 Feb 2026, 20:46
VIKING GLOBAL INVESTORS LP	8.2%	-15%	$825,530,932	15,893,934	-2,708,986	-15%	$51.94	13D/A	14 Nov 2025	14 Nov 2025, 16:52
HALVORSEN OLE ANDREAS	9.7%	-1%	$864,477,692	18,602,920	0		$46.47	13D/A	14 Aug 2025	14 Aug 2025, 20:32
VIKING GLOBAL INVESTORS LP	9.8%	-16%	$745,791,063	18,602,920	-3,452,455	-16%	$40.09	13D/A	27 Jun 2025	01 Jul 2025, 19:49
VIKING GLOBAL INVESTORS LP	12%		$793,111,285	22,055,375			$35.96	13D/A	31 Jan 2025	12 Mar 2025, 16:28
VIKING GLOBAL INVESTORS LP	12%		$793,111,285	22,055,375			$35.96	13D/A	31 Jan 2025	31 Jan 2025, 19:18

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.9%	-0.32%	$1,100,992,012	14,393,934	-1,583,915	-9.9%	$76.49	Q4 2025
30 Sep 2025	2.2%	-0.35%	$829,889,477	15,977,849	-2,577,526	-14%	$51.94	Q3 2025
30 Jun 2025	2.3%	-0.44%	$801,221,093	18,555,375	-3,500,000	-16%	$43.18	Q2 2025
31 Mar 2025	2.4%	-0.34%	$762,454,314	22,055,375	-3,065,616		$34.57	Q1 2025
31 Dec 2024	2.2%	0%	$689,319,993	25,120,991	0		$27.44	Q4 2024
30 Sep 2024	2.3%	0%	$639,580,431	25,120,991	0		$25.46	Q3 2024
30 Jun 2024	2.4%	0%	$636,314,702	25,120,991	0		$25.33	Q2 2024
31 Mar 2024	2.9%	0%	$776,741,042	25,120,991	0		$30.92	Q1 2024
31 Dec 2023	3.7%	0%	$1,014,134,407	25,120,991	0		$40.37	Q4 2023
30 Sep 2023	2.7%	-0.16%	$662,440,533	25,120,991	-1,500,000	-5.6%	$26.37	Q3 2023
30 Jun 2023	1.9%	0%	$457,881,045	26,620,991	0		$17.20	Q2 2023
31 Mar 2023	2.1%	0%	$441,376,031	26,620,991	0		$16.58	Q1 2023
31 Dec 2022	1%	0%	$202,851,951	26,620,991	0		$7.62	Q4 2022
30 Sep 2022	1.2%	0%	$264,613,000	26,620,991	0		$9.94	Q3 2022
30 Jun 2022	1.1%	0%	$241,719,000	26,620,991	0		$9.08	Q2 2022
31 Mar 2022	1.1%	0%	$270,203,000	26,620,991	0		$10.15	Q1 2022
31 Dec 2021	1.3%	0%	$444,038,000	26,620,991	0		$16.68	Q4 2021
30 Sep 2021	3.4%	0%	$1,247,726,000	26,620,991	0		$46.87	Q3 2021
30 Jun 2021	4.9%	0%	$1,622,816,000	26,620,991	0		$60.96	Q2 2021
31 Mar 2021	4.9%	0%	$1,639,853,000	26,620,991	0		$61.60	Q1 2021
31 Dec 2020	5.2%	0%	$1,893,019,000	26,620,991	0		$71.11	Q4 2020
30 Sep 2020	3.6%	0%	$998,820,000	26,620,991	0		$37.52	Q3 2020
30 Jun 2020	3.8%	0%	$868,111,000	26,620,991	0		$32.61	Q2 2020
31 Mar 2020	4%	0%	$772,009,000	26,620,991	0		$29.00	Q1 2020
31 Dec 2019	4.4%	0%	$933,066,000	26,620,991	0		$35.05	Q4 2019
30 Sep 2019	3%	0%	$571,553,000	26,620,991	0		$21.47	Q3 2019
30 Jun 2019	3.2%	+3.2%	$717,968,000	26,620,991	+26,620,991	NEW	$26.97	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.